我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
66
28 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
N/A
进行中(未招募)
4
6.1%
已完成
15
22.7%
尚未招募
24
36.4%
招募中
20
30.3%
暂停
3.0%
终止
1.5%
TGA
Therapeutic Goods Administration
- The NSW Government has awarded $800,000 in Clinical Trials Fellowship grants to improve cancer clinical trial access for rural and regional patients across the state. - Three grants worth $200,000 each focus on regional initiatives including remote trial delivery frameworks, teletrials, and engagement with underrepresented populations. - A fourth $200,000 grant supports the ACTIvate study for anaplastic thyroid cancer immunotherapy, building on global evidence to address unique treatment challenges. - The funding is part of Cancer Institute NSW's annual $5 million investment in cancer clinical trials, aiming to ensure equitable access regardless of geographic location.